4th Annual Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress
10 March - 11 March
Devising the effective manufacturing and quality control methods of cell therapies
Regenerative therapies are proving its acceptance in the potential of cell-based therapies for chronic disorders. Since our past three editions, our aim through this conference is to provide an illustrative approach to recent developments in technologies of bioprocessing of cellular therapies, to process development and addressing qualitative and regulatory hurdles.
In the 4th edition of MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine, we would be focusing on the manufacturing, clinical and regulatory aspects of cell therapies and regenerative medicine. The special impact would be laid on tissue engineering, car-T cell-based immunotherapies, automated manufacturing, allogeneic therapies, with the aspects of hurdles in supply chain management and regulatory affairs.